Drug Discovery CRO – Kinetic Profiling Expertise | Enzymlogic
Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic has attracted investment from public and private investors that recognize the truly innovative nature of our disruptive technology, talent and commitment of our team, and drive to be the leading company in kinetic analysis for drug discovery, globally. We are developing the DYRK1A kinase inhibitor Leucettinib-21 as a new drug candidate for Downs syndrome and Alzheimer’s disease. We enjoyed dealing with Enzymlogic’s friendly, professional, responsive team, whose technology is great for kinase inhibitors developers and fans! We are continuously introducing innovative solutions across different therapeutic areas and targets to meet the challenges of our clients and accelerate their R&D activities. This is why we are always on the lookout for new ideas and ways to give them space to grow. Of partners: 1Coordinating company: Enzymlogic S.L.Funding institution: CDTIPeriod: 2015-2017. Of partners: 1Coordinating company: Enzymlogic S.L.Funding institution: European UnionPeriod: 2019.
This company is:
Verified
Expanding our kinetic services globally | Enzymlogic
Enzymlogic has been granted with the ICEX Next programme for internationalization. ICEX Next combines consulting and economic funding to promote the internationalization of the Spanish companies. This integral practical programme supports the companies along the different phases of their international projects, both in the initiation and consolidation in foreign markets. About Enzymlogic Enzymlogic offers in vitro...
Verified
Enzymlogic presents its Binding Kinetics Platform at 18th Drug Discovery Summit | Enzymlogic
A Binding Kinetics Platform that boosts the understanding of drug efficacy in vivo. Enzymlogic announce the presentation of results achieved with its Binding Kinetic Platform in the evaluation of the kinetic profile of kinase-marketed drugs. The poster entitled “Profiling the kinetic selectivity of kinase As the kickoff to the 18th Drug Discovery Summit in Berlin, Germany on June...
Verified
Discover our binding kinetics platform at FarmaForum 2015 | Enzymlogic
A binding kinetics platform that guides the kinetic optimization of drug candidates and accelerates the drug discovery process. The Forum for the pharmaceutical, cosmetics and technology laboratories, FarmaForum, will be held in Madrid from 4-5 March, bringing together the entire Life Sciences and Pharmaceutical Industry, and making up a comprehensive showcase of new developments relating...
View all products
Keywords
Industries
TIME Project – GPCR Kinetic Profiling | Enzymlogic
Our TIME project involves the design and development of a disruptive technology platform to evaluate the kinetic profile of GPCRs
Where is Enzymlogic located?
The company Enzymlogic is located in Madrid, Community of Madrid, Spain. It's worth noting that the company may has more corporate locations
How many employees does Enzymlogic approximately have?
As of the latest available information Enzymlogic has around 1-10 employees worldwide.
When was Enzymlogic founded?
Enzymlogic was founded in 2013
In which industries does Enzymlogic mainly work?
The company Enzymlogic has it's main focus in the industries of Biotechnology, Science and Engineering, Health Care
Lysislogic Scientific Inc.
Canada
1-10 Employees
2019
EnginZyme
Sweden
1-10 Employees
2014
Enzymicals
Germany
11-50 Employees
2009
Logos Capital
United States
1-10 Employees
2019
Allozymes
Singapore
1-10 Employees
2019
Limelogic AB
Sweden
1-10 Employees
Enzychem Lifesciences
Russia
51-100 Employees
Structural Biology and Biophysical Chemistry Laboratory
United Arab Emirates
1-10 Employees
2012
Topics which have been searched by others and may be interesting for you:
